DYAI Stock Analysis: Buy, Sell, or Hold?
DYAI - Dyadic International, Inc.
$0.68
-0.01 (-1.55%)
▼
5d:
-12.94%
30d:
-42.92%
90d:
-10.52%
HOLD
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When DYAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DYAI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: DYAI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: DYAI is currently trading at $0.68, which is considered oversold relative to its 30-day fair value range of $0.80 to $1.21. From a valuation perspective, the stock is trading at a discount (Forward PE: 29.1) compared to its historical average (45.2). Remarkably, the market is currently pricing in an annual earnings decline of 13.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DYAI is in a uptrend. The price is currently testing key support at $0.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DYAI scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.50 (+709.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DYAI is in a uptrend. The price is currently testing key support at $0.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DYAI scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.50 (+709.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.80 -
$1.21
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 709.7% below Wall St target ($5.50)
- CAUTION: Bottoming setup, but lagging the sector by 40% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-12.9%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.80 -
$1.21
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.67
Resistance Level
$1.10
Current Trend
Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
29.15
Wall Street Target
$5.50
(+709.7%)
Revenue Growth (YoY)
-0.6%
Profit Margin
-200.5%
Valuation Discount vs History
-13.6% cheaper
PE vs Historical
29.2 vs 45.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.6%
(market-implied from PE analysis)
1-Year Target
$0.61
(-10%)
2-Year Target
$0.55
(-19%)
3-Year Target
$0.50
(-27%)
3-Yr Target (if PE normalizes)
(PE: 29→45)
$0.77
(+13%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 29.2 to 45.2
Stabilization Target:
$1.05
(+55.0%)
PE Expansion Potential:
+55.0%
Share & Embed Analysis
Last updated: August 24, 2026 8:17 PM ET
Data refreshes hourly during market hours. Next update: 9:17 PM
Data refreshes hourly during market hours. Next update: 9:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DYAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 62 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 37 SELL |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 47 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
